Matthias Alder - Chief Executive Officer, Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
GANX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthias Alder since 31 Dec 2024

Holdings reported by Matthias Alder for Gain Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (right to buy) 370,000 $2,168,200 $5.86 21 Mar 2024 Direct Common Stock
Common Stock 21,140 $85,828 $4.06 26 Mar 2024 Direct
Restricted Stock Units 6,376 $24,605 $3.86 26 Mar 2024 Direct Common Stock

Transactions reported by Matthias Alder for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.